GB1508168A - 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins - Google Patents
11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandinsInfo
- Publication number
- GB1508168A GB1508168A GB50700/75A GB5070075A GB1508168A GB 1508168 A GB1508168 A GB 1508168A GB 50700/75 A GB50700/75 A GB 50700/75A GB 5070075 A GB5070075 A GB 5070075A GB 1508168 A GB1508168 A GB 1508168A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- phenyl
- thienyl
- naphthyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- -1 tropanyl Chemical group 0.000 abstract 4
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 3
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 3
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 150000003180 prostaglandins Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53167674A | 1974-12-11 | 1974-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1508168A true GB1508168A (en) | 1978-04-19 |
Family
ID=24118594
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB29060/77A Expired GB1508169A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopenta(b)furan compounds useful in the synthesis of prostaglandin analogues |
| GB29061/77A Expired GB1508170A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopentane compounds useful as intermediates in the synthesis of prostaglandin analogues |
| GB50700/75A Expired GB1508168A (en) | 1974-12-11 | 1975-12-10 | 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB29060/77A Expired GB1508169A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopenta(b)furan compounds useful in the synthesis of prostaglandin analogues |
| GB29061/77A Expired GB1508170A (en) | 1974-12-11 | 1975-12-10 | Substituted cyclopentane compounds useful as intermediates in the synthesis of prostaglandin analogues |
Country Status (22)
| Country | Link |
|---|---|
| JP (3) | JPS51125257A (hu) |
| AT (1) | AT351185B (hu) |
| BE (1) | BE836564A (hu) |
| BG (1) | BG27227A3 (hu) |
| CH (1) | CH610302A5 (hu) |
| CS (3) | CS194745B2 (hu) |
| DD (3) | DD125828A5 (hu) |
| DE (1) | DE2555210A1 (hu) |
| DK (1) | DK559975A (hu) |
| ES (1) | ES443421A1 (hu) |
| FI (1) | FI753475A (hu) |
| FR (1) | FR2293923A1 (hu) |
| GB (3) | GB1508169A (hu) |
| GR (1) | GR60310B (hu) |
| IE (1) | IE43815B1 (hu) |
| IL (2) | IL48617A0 (hu) |
| LU (1) | LU73997A1 (hu) |
| NL (1) | NL166015C (hu) |
| NO (1) | NO754195L (hu) |
| NZ (1) | NZ179502A (hu) |
| SE (1) | SE7513602L (hu) |
| ZA (1) | ZA747723B (hu) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586468B1 (en) | 1998-09-14 | 2003-07-01 | Ono Pharmaceutical Co., Ltd. | ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
| BRPI0619492A2 (pt) * | 2005-12-07 | 2011-10-04 | Univ Ramot | derivados quìmicos de jasmonato, composições famacêuticas e métodos de uso dos mesmos |
| US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| WO2014015247A1 (en) | 2012-07-19 | 2014-01-23 | Cayman Chemical Company, Inc. | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES416865A1 (es) * | 1972-07-13 | 1976-03-01 | Pfizer | Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15. |
-
1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/xx unknown
-
1975
- 1975-11-11 GR GR49337A patent/GR60310B/el unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/xx unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/xx unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/de active Pending
- 1975-12-10 NZ NZ179502A patent/NZ179502A/xx unknown
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-10 DK DK559975A patent/DK559975A/da not_active Application Discontinuation
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-11 AT AT941675A patent/AT351185B/de not_active IP Right Cessation
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 ES ES443421A patent/ES443421A1/es not_active Expired
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 CS CS771241A patent/CS194745B2/cs unknown
- 1975-12-11 DD DD7500197926A patent/DD129649A5/xx unknown
- 1975-12-11 BG BG031757A patent/BG27227A3/bg unknown
- 1975-12-11 CS CS771242A patent/CS194746B2/cs unknown
- 1975-12-11 BE BE1007076A patent/BE836564A/xx not_active IP Right Cessation
- 1975-12-11 DD DD7500197925A patent/DD129783A5/xx unknown
- 1975-12-11 CH CH1610875A patent/CH610302A5/xx not_active IP Right Cessation
- 1975-12-11 FR FR7537944A patent/FR2293923A1/fr active Granted
- 1975-12-11 CS CS758428A patent/CS194733B2/cs unknown
- 1975-12-11 NL NL7514446.A patent/NL166015C/xx not_active IP Right Cessation
- 1975-12-11 JP JP50148319A patent/JPS51125257A/ja active Pending
-
1977
- 1977-03-11 JP JP2687477A patent/JPS52102270A/ja active Pending
- 1977-03-11 JP JP2687577A patent/JPS52102258A/ja active Pending
-
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586468B1 (en) | 1998-09-14 | 2003-07-01 | Ono Pharmaceutical Co., Ltd. | ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS51125257A (en) | 1976-11-01 |
| CH610302A5 (en) | 1979-04-12 |
| NL166015C (nl) | 1981-06-15 |
| GR60310B (en) | 1978-05-08 |
| FI753475A (hu) | 1976-06-12 |
| ES443421A1 (es) | 1977-04-16 |
| NZ179502A (en) | 1979-01-11 |
| GB1508170A (en) | 1978-04-19 |
| FR2293923B1 (hu) | 1979-02-23 |
| CS194746B2 (en) | 1979-12-31 |
| SE7513602L (sv) | 1976-06-14 |
| CS194745B2 (en) | 1979-12-31 |
| IE43815B1 (en) | 1981-06-03 |
| CS194733B2 (en) | 1979-12-31 |
| NO754195L (hu) | 1976-06-14 |
| IL56863A0 (en) | 1979-05-31 |
| BG27227A3 (bg) | 1979-09-14 |
| IE43815L (en) | 1976-06-11 |
| ATA941675A (de) | 1978-12-15 |
| FR2293923A1 (fr) | 1976-07-09 |
| JPS52102270A (en) | 1977-08-27 |
| DD129783A5 (de) | 1978-02-08 |
| IL48617A0 (en) | 1976-02-29 |
| JPS52102258A (en) | 1977-08-27 |
| AU8736275A (en) | 1977-10-13 |
| DE2555210A1 (de) | 1976-06-16 |
| DK559975A (da) | 1976-06-12 |
| NL7514446A (nl) | 1976-06-15 |
| NL166015B (nl) | 1981-01-15 |
| ZA747723B (en) | 1976-11-24 |
| GB1508169A (en) | 1978-04-19 |
| DD125828A5 (hu) | 1977-05-18 |
| LU73997A1 (hu) | 1976-11-11 |
| DD129649A5 (de) | 1978-02-01 |
| AT351185B (de) | 1979-07-10 |
| BE836564A (fr) | 1976-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1515414A (en) | 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins | |
| US4096179A (en) | 13,14-Dihydro-16-phenoxy prostaglandin F1α analogs | |
| IE43916L (en) | Allenic prostaglandins | |
| GB1507211A (en) | Prostaglandin analogues | |
| IE34511L (en) | Piperazine ethers. | |
| GB1508168A (en) | 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins | |
| GB1497218A (en) | Thiaprostaglandins | |
| GB1450691A (en) | Prostaglandin analogues | |
| GB1506822A (en) | Prostaglandins | |
| GB1506817A (en) | Prostaglandins | |
| GB1396206A (en) | Prostaglandins and the preparation thereof | |
| GB1285372A (en) | Improvements in or relating to prostaglandins and the preparation thereof | |
| GB1431414A (en) | Prostanoic acid derivatives | |
| IE42748L (en) | New prostanoic acid derivatives and process for their¹manufacture | |
| GB1398291A (en) | Prostaglandin analogues and production thereof | |
| GB1436831A (en) | Prostaglandins and the preparation thereof | |
| GB1496851A (en) | Prostynoic acid derivatives | |
| GB1525282A (en) | 16-chloroprostaglandin analogues | |
| GB1493557A (en) | Fluoro-prostaglandins and process for their preparation | |
| GB1373878A (en) | Prostaglandins and the preparation thereof | |
| GB1464205A (en) | Prostaglandins | |
| GB1434620A (en) | Prostaglandins and the preparation thereof | |
| GB1438093A (en) | Prostaglandins and the manufacture thereof | |
| GB1463790A (en) | Prostaglandins | |
| GB1482010A (en) | Prostaglandin analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 48S | Specification amended (sect. 8/1949) | ||
| SPA | Amended specification published | ||
| PCNP | Patent ceased through non-payment of renewal fee |